Morgan Stanley Illumina, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Illumina, Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,604,042 shares of ILMN stock, worth $232 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,604,042

Previous 1,950,610 17.77%

Holding current value

$232 Million

Previous $204 Million 2.73%

% of portfolio

0.02%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$105.28 - $135.9 $36.5 Million - $47.1 Million	-346,568 Reduced 17.77%	1,604,042 $209 Million
Q2 2024 Oct 17, 2024	SELL	$101.05 - $133.57 $167 Million - $221 Million	-1,657,357 Reduced 45.94%	1,950,610 $204 Million
Q2 2024 Aug 14, 2024	SELL	$101.05 - $133.57 $167 Million - $221 Million	-1,657,357 Reduced 45.94%	1,950,610 $204 Million
Q1 2024 Oct 17, 2024	BUY	$127.73 - $147.2 $212 Million - $244 Million	1,657,357 Added 84.97%	3,607,967 $495 Million
Q1 2024 Aug 16, 2024	SELL	$127.73 - $147.2 $11.5 Million - $13.3 Million	-90,262 Reduced 2.44%	3,607,967 $495 Million
Q1 2024 May 15, 2024	SELL	$127.73 - $147.2 $11.5 Million - $13.3 Million	-90,262 Reduced 2.44%	3,607,967 $495 Million
Q4 2023 Aug 16, 2024	BUY	$92.79 - $142.53 $162 Million - $249 Million	1,747,619 Added 89.59%	3,698,229 $515 Million
Q4 2023 Feb 13, 2024	BUY	$92.79 - $142.53 $13.3 Million - $20.4 Million	143,262 Added 4.03%	3,698,229 $515 Million
Q3 2023 Nov 15, 2023	SELL	$128.91 - $192.44 $514 Million - $768 Million	-3,990,000 Reduced 52.88%	3,554,967 $488 Million
Q2 2023 Aug 14, 2023	BUY	$183.43 - $232.67 $519 Million - $658 Million	2,829,291 Added 60.0%	7,544,967 $1.41 Billion
Q1 2023 May 15, 2023	SELL	$193.75 - $232.55 $76.8 Million - $92.2 Million	-396,544 Reduced 7.76%	4,715,676 $1.1 Billion
Q4 2022 Feb 14, 2023	BUY	$187.24 - $242.74 $361 Million - $468 Million	1,927,673 Added 60.53%	5,112,220 $1.03 Billion
Q3 2022 Nov 14, 2022	BUY	$177.23 - $227.44 $54.6 Million - $70 Million	307,952 Added 10.71%	3,184,547 $608 Million
Q2 2022 Oct 27, 2022	BUY	$181.58 - $368.0 $177 Million - $358 Million	972,800 Added 51.1%	2,876,595 $530 Million
Q2 2022 Aug 15, 2022	BUY	$181.58 - $368.0 $177 Million - $358 Million	972,800 Added 51.1%	2,876,595 $530 Million
Q1 2022 Oct 27, 2022	SELL	$303.87 - $423.8 $296 Million - $412 Million	-972,800 Reduced 33.82%	1,903,795 $665 Million
Q1 2022 May 13, 2022	BUY	$303.87 - $423.8 $220 Million - $307 Million	724,105 Added 61.38%	1,903,795 $665 Million
Q4 2021 Feb 14, 2022	SELL	$347.28 - $421.83 $18.4 Million - $22.4 Million	-53,069 Reduced 4.3%	1,179,690 $449 Million
Q3 2021 Nov 15, 2021	BUY	$405.61 - $524.84 $500 Million - $647 Million	1,232,759 New	1,232,759 $500 Million

Others Institutions Holding ILMN

# of Institutions

901

Shares Held

137M

Call Options Held

1.22M

Put Options Held

1.43M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.7B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account